Editorial
doi: 10.1016/s0195-668x(02)00610-3.
Myocardial contrast echocardiography in the assessment of pharmacologic intervention of the reperfusion injury
- PMID: 12559933
- DOI: 10.1016/s0195-668x(02)00610-3
Item in Clipboard
Editorial
Myocardial contrast echocardiography in the assessment of pharmacologic intervention of the reperfusion injury
Eur Heart J.
2003 Jan.
No abstract available
Comment on
-
Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty.Eur Heart J. 2003 Jan;24(1):67-76. doi: 10.1016/s0195-668x(02)00324-1. Eur Heart J. 2003. PMID: 12559938 Clinical Trial.
Similar articles
-
On the use of abciximab in percutaneous coronary intervention.Dan Med Bull. 2011 Aug;58(8):B4312. Dan Med Bull. 2011. PMID: 21827726 Review. No abstract available.
-
Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction.J Invasive Cardiol. 2002 Feb;14(2):100-4; quiz 104-5. J Invasive Cardiol. 2002. PMID: 11818648 No abstract available.
-
Abciximab in the treatment of ST-segment elevation myocardial infarction.JAMA. 2005 Oct 12;294(14):1760-1; author reply 1761. doi: 10.1001/jama.294.14.1760-b. JAMA. 2005. PMID: 16219877 No abstract available.
-
[Gastrointestinal bleeding in a patient with acute myocardial infarction treated with primary coronary angioplasty and abciximab (ReoPro) administration].Kardiol Pol. 2006 Mar;64(3):334-6; discussion 337-8. Kardiol Pol. 2006. PMID: 16583343 Polish. No abstract available.
-
Role of glycoprotein IIb/IIIa-receptor inhibitors in managing ST-segment-elevation myocardial infarction.Am J Health Syst Pharm. 2002 Nov 1;59(21 Suppl 7):S27-36. doi: 10.1093/ajhp/59.suppl_7.S27. Am J Health Syst Pharm. 2002. PMID: 12434712 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
